Research Paper Volume 14, Issue 17 pp 6917—6935
Identification of immune subtypes to guide immunotherapy and targeted therapy in clear cell renal cell carcinoma
Figure 4. Identification of differential expression of immune checkpoints and mTOR among immune-related subtypes. (A) Differential expression of PDCD1, PD-L1, and CTLA4 among the ccRCC immune subtypes in TCGA cohorts. (B) Differential proportion of PDCD1+, PD-L1+, and CTLA4+ among the ccRCC immune subtypes in TCGA cohorts. (C) Differential expression and proportion of mTOR+ among the ccRCC immune subtypes in TCGA cohorts.